TITLE

326. Measure of renal function a valuable tool to evaluate cardiovascular risk assessment

AUTHOR(S)
Henry, R.M.A.; Kostense, P. J.; Bos, G.
PUB. DATE
May 2003
SOURCE
Kidney;May/Jun2003, Vol. 12 Issue 3, p115
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: To investigate the association of renal function with all-cause and cardiovascular mortality in a population-based cohort and explore potential mechanisms underlying any such relationship. Methodology: An age-, sex-, and glucose tolerance stratified sample (n = 631 ) of a population-based cohort aged 50-75 years was followed prospectively. After up to 10.2 years of follow-up, 117 subjects had died (50 of cardiovascular causes). Results: At baseline, metal age was 64 ± 7 years, 48% were men, 55% had hypertension, and 27% (by design) had type 2 diabetes. Serum creatinine was 91.7 ± 19.0 μmoL/L; creatinine clearance, as estimated by the Cockroft-Gault formula, was 72.5 ± 13.7 mL/min/1.73 m², and glomerular filtration rate (GFR), estimated by Levey's equation, was 67.8 ± 12.1 mL/min/1.73 m². Renal function was inversely associated with all-cause and with cardiovascular mortality. Ralative risks were 1.08 (1.04-1.13) and 1.11 (1.07-1.16) per 5 μmoL/L increase of serum creatinine; 1.07 (0.98-1.17) and 1.15 (1.01-1.31 ) for each decrease of 5 mL/min/1.73 m² creatinine clearance; and 1.15 (1.05-l.26) and 1.26 (1.12-1.42) for each decrease of 5 mL/min/1.73 m² of GFR. These associations remained alter adjusting for age, sex, glucose tolerance status, hypertension, prior cardiovascular disease, low-density lipoprotein cholesterol, homocysteine, (micro)athuminuria, von Willebrand factor, soluble vascular adhesion molecule 1, and C-reactive protein. Analyses of diabetic and hypertensive subjects gave similar results. Conclusion: Mild to moderate loss of renal function is strongly associated with an increased risk of cardiovascular mortality.
ACCESSION #
10145664

 

Related Articles

  • Nondiabetic Renal Disease in type 2 Diabetes Mellitus Patients: A Clinicopathological Study. Clement Wilfred, Devadass; Viswanath Mysorekar, Vijaya; Venkataramana, Raju S.; Eshwarappa, Mahesh; Subramanyan, Revathi // Journal of Laboratory Physicians;Jul-Dec2013, Vol. 5 Issue 2, p94 

    Background: The prevalence of nondiabetic renal disease (NDRD) among type 2 diabetics varies widely depending on the populations being studied and the selection criteria. Also, for patients found to have NDRD different predicting factors have been identified by different studies. Objectives: To...

  • Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study. Cea-Calvo, Luis; Conthe, Pedro; Gómez-Fernández, Pablo; De Alvaro, Fernando; Fernández-Pérez, Cristina // Cardiovascular Diabetology;2006, Vol. 5, p23 

    Background: Target organ damage (mainly cardiac and renal damage) is easy to evaluate in outpatient clinics and offers valuable information about patient's cardiovascular risk. The purpose of this study was to evaluate, using simple methods, the prevalence of cardiac and renal damage and its...

  • The Relationship Between Renal Dysfunction and Major Cardiovascular Outcomes in Patients with Diabetes: Experience from PROactive. Schneider, Christian A.; Yates, John; Erdmann, Erland // Diabetes;Jun2007 Supplement 1, Vol. 56, pA177 

    Renal dysfunction, as measured by reduced glomerular filtration rate (GFR), is a potent independent marker of poor prognosis in the general population, as well as in patients with hypertension, acute coronary, syndromes or diabetes mellitus. We further investigated the relationship between renal...

  • The impact of type II diabetes mellitus in patients with autosomal dominant polycystic kidney disease. Reed, Berenice; Helal, Imed; McFann, Kim; Wang, Wei; Yan, Xiang-Dong; Schrier, Robert W. // Nephrology Dialysis Transplantation;Jul2012, Vol. 27 Issue 7, p2862 

    Background The epidemic of obesity and diabetes is increasing within the USA and worldwide. We have previously shown that body mass index has increased significantly in autosomal dominant polycystic kidney disease (ADPKD) subjects seen at our center in more recent years. However, the impact of...

  • DIABETES MELLITUS TYPE 2 IS NOT A RISK FACTOR FOR AMINOGLYCOSIDE INDUCED RENAL INJURY. Sweileh, Waleed M.; Sawalha, Ansam F.; Taha, Adham S. Abu // Diabetologia Croatica;2011, Vol. 40 Issue 1, p17 

    The aim of the study was to investigate the extent and time course of aminoglycoside (AG)-induced serum creatinine elevation in patients with and without type 2 diabetes mellitus (DM2). This prospective study included patients with and without DM2 who were administered AG parenterally. The...

  • Albuminuria stage and CVD risk in T2D.  // Diabetes Digest;2012, Vol. 11 Issue 3, p159 

    The article discusses a study to evaluate chronic kidney disease (CKD) and renal-cardiovascular outcomes in type 2 diabetes (T2D) without prevalent cardiovascular disease, which revealed the importance of reducing albuminuria in T2D.

  • Association of Lower Plasma Fetuin-A Levels With Peripheral Arterial Disease in Type 2 Diabetes. Eraso, Luis H.; Ginwala, Naeema; Qasim, Atif N.; Mehta, Nehal N.; Dlugash, Rachel; Kapoor, Shiv; Schwartz, Stanley; Schutta, Mark; Iqbal, Nayyar; Mohler III, Emile R.; Reilly, Muredach P. // Diabetes Care;Feb2010, Vol. 33 Issue 2, p408 

    OBJECTIVE -- Fetuin-A is an inhibitor of vascular calcification and a mediator of insulin resistance. This study evaluated the association of plasma fetuin-A and peripheral arterial disease (PAD). RESEARCH DESIGN AND METHODS -- A total of 738 individuals with type 2 diabetes (mean age 58.7...

  • Comparison of Two Creatinine-Based Estimating Equations in Predicting All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes. ZOPPINI, GIACOMO; MANTOVANI, WILLIAM; CHONCHOL, MICHEL; NEGRI, CARLO; STOICO, VINCENZO; MANTOVANI, ALESSANDRO; DE SANTI, FRANCESCA; BONORA, ENZO; TARGHER, GIOVANNI // Diabetes Care;Nov2012, Vol. 35 Issue 11, p2347 

    OBJECTIVE--To compare the performance of two glomerular filtration rate (GFR)-estimating equations in predicting the risk of all-cause and cardiovascular mortality in type 2 diabetic patients. RESEARCH DESIGN AND METHODS--We followed 2,823 type 2 diabetic outpatients for a period of 6 years for...

  • Simple Cystatin C Formula for Estimation of Glomerular Filtration Rate in Overweight Patients with Diabetes Mellitus Type 2 and Chronic Kidney Disease. Bevc, Sebastjan; Hojs, Radovan; Ekart, Robert; Završnik, Matej; Gorenjak, Maksimiljan; Puklavec, Ludvik // Experimental Diabetes Research;2012, Special section p1 

    In clinical practice the glomerular filtration rate (GFR) is estimated from serum creatinine-based equations like the Cockcroft-Gault formula (C&G) and Modification of Diet in Renal Disease formula (MDRD). Recently, serum cystatin C-based equations, the newer creatinine formula (The Chronic...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics